PROBISEARCH, a leading company in research on probiotics, together with Zinereo Pharma, have completed the development of two products from the dermatology line: BASE 10201 and Lalacell, two new innovative probiotic solutions that respect the natural microbiome of the skin.
BASE 10201 is an ultra-concentrated serum with a light, fresh and quickly absorbed texture that contains the secreted essence of the probiotic Bifidobacterium adolescentis PS10201 (Bifida ferment filtrate), which exerts a firming effect favoring the production of elastin and collagen, which helps promote young and firm skin.
Lalacell is a regenerating cream that includes inactivated cells of the probiotic strain Lactococcus lactis PS11802 (Lactococcus ferment lysate) as an ingredient. It is an innovative probiotic solution that acts on the superficial and deeper layers of the skin, promoting the active recovery of fibroblasts and keratinocytes, inducing their regeneration and promoting the natural renewal of the skin.
BASE 10201 and Lalacell are the result of the joint research and development of Zinereo Pharma and Probisearch (Zendal Group) with the aim of offering innovative probiotic cosmetic formulations for the care and balance of the natural microbiome of the skin. These two products are incorporated into the Zinereo Pharma Vademecum.
PROBISEARCH is a company located in the Madrid Technology Park, founded in 2011 by a group of scientists from the Complutense University of Madrid with the mission of offering new probiotic alternatives to prevent and treat various human and veterinary diseases related to the microbiota.
PROBISEARCH was acquired in 2016 by the Zendal biotechnology group with the aim of persisting in this mission and integrating this knowledge and experience into a more comprehensive offer in the field of Probiotics aimed at the world of human and animal health.